Gout market across 7MM set to reach $10.8 bn in 2032 fueled by novel ULTs and rising prevalence: GlobalData Read more
J&J acquisition of Ambrx bolsters cancer ADC portfolio amidst big pharma’s growing investment trend: GlobalData Read more